B. Riley Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

B. Riley Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,195	Closed	-$10.8K	–	1642
2022 Q4	$10.8K	Hold	12,195	–	–	﹤0.01%	1466
2022 Q3	$20K	Buy	+12,195	New	+$27.7K	﹤0.01%	1422
2021 Q4	–	Sell	-17,400	Closed	-$133K	–	1517
2021 Q3	$133K	Sell	17,400 -3,918	-18%	-$33.2K	﹤0.01%	1303
2021 Q2	$207K	Sell	21,318 -14,750	-41%	-$117K	0.01%	1205
2021 Q1	$299K	Sell	36,068 -4,238	-11%	-$44.8K	0.01%	1003
2020 Q4	$276K	Buy	40,306 +12,919	+47%	+$104K	0.01%	806
2020 Q3	$304K	Sell	27,387 -7,539	-22%	-$69K	0.02%	713
2020 Q2	$220K	Buy	+34,926	New	+$134K	0.01%	743

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return